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Gallstones
AbsTrACT
Objectives Gallstone disease (cholelithiasis) has a 
familial component, but detailed data on the modification 
of familial risk are lacking. Using nationwide hospital 
and population records, we aimed to determine detailed 
familial risks for medically diagnosed gallstone disease.
Design Subjects were obtained from the Multigeneration 
Register, which contains family data on the Swedish 
population, and patients with gallstone disease 
were identified from the Hospital Discharge Register 
(1964–2015) and the Outpatient Register (2001–2015). 
Standardised incidence ratios (SIRs) were calculated as 
the ratio of observed to expected number of cases.
results Gallstone disease was diagnosed in 660 732 
patients, with an overall incidence of 131 per 100 000 
person-years. Familial cases accounted for 36.0% of 
all patients with gallstone disease. Of these, 50.9% 
had a parental family history (SIR 1.62), 35.1% 
had a sibling history (SIR 1.75) and 14.0% had a 
parental+sibling history (SIR 2.58). Among a total of 
54 630 affected siblings, 84.4% were sibling pairs (SIR 
1.55). However, the remaining 15.6% of the affected 
siblings constituted the high-risk group of multiple 
affected siblings and an SIR >10; these persons 
accounted for 7.7% of all familial cases. The spousal 
risk was only slightly increased to 1.18.
Conclusions Overall, the results point to the underlying 
genetic causes for the observed familial clustering, 
which may involve polygenic gene–environmental 
interactions for most familial cases but high-risk genes 
in close to 10% of cases. Family histories should be 
taken into account in the medical setting and used for 
counselling of at-risk individuals.
IntroductIon
Gallstones grow inside the gallbladder or 
biliary tract and if symptomatic they consti-
tute gallstone disease or cholelithiasis.1 Gall-
stones may be classified by their composition 
into common cholesterol gallstones and 
bilirubin stones, by their colour into black 
pigment stones caused by haemolysis and 
brown pigment stones caused by obstructed 
or infected bile ducts, and by their locali-
sation most commonly in the gallbladder 
or in the biliary tract.2 Over 10% of the US 
and European populations develop gall-
stones and the condition is becoming more 
widespread due to the increasing prevalence 
of risk factors such as obesity and physical 
inactivity.1 3 Other risk factors are female 
sex, high age, pregnancy, certain ethnic 
background, family history and genetics.3 
However, the female excess incidence could 
not be found in Taiwanese vegetarians.4 
Gallstone disease has important medical 
consequences and costs; prevention should 
be of high priority.5 6 
Based on familial clustering of gallstone 
disease, a 2.2-fold to 4.5-fold elevated risk 
has been reported in case–control studies 
among first-degree relatives and herita-
bility estimates of 25% to 29% have been 
summary box
What is already known about this subject?
 ► It is known that gallstone disease runs in families, 
but how the risk is modified by a detailed family 
history is  not known.
 ► Germline gene variants have been associated with 
the risk of gallstone disease.
What are the new findings?
 ► Familial cases accounted for 36.0% of all patients 
with gallstone disease.
 ► Of familial cases, 50.9% had a parental family 
history with a standardised incidence ratio (SIR) 
of 1.62 compared with those without the family 
history.
 ► Of familial cases, 35.1% had a sibling history with 
an SIR of 1.75.
 ► Of familial cases, 14.0% had a 
parental+sibling history with an SIR of 2.58.
 ► Among the affected siblings, 15.6% were from 
families of two or more siblings diagnosed with an 
SIR >10.
 ► The spousal risk was only 1.18.
How might it impact on clinical practice in the 
foreseeable future?
 ► Family histories should be taken when patients are 
diagnosed with gallstones.
 ► It would be important to identify the high-risk 
families and target counselling at patients and 
healthy individuals from such families.
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derived from family and twin studies.7–9 In one study, 
young women were at particular risk and the authors 
suggested that ‘female relatives of young gallstone 
patients should be routinely screened for gallstones’.7 
A family study from the 1960s found no increased risk 
for gallstones among spouses, which suggests purely 
genetic origin for the familial clustering of gallstone 
disease.10 Several susceptibility genes have been iden-
tified, including apolipoproteins E (APOE) and B (APOB), 
cholesterol ester transporting protein (CETP), cholesterol 7 
α-hydroxylase (CYP7A1), cholecystokinin receptor A (CCKAR) 
and LDL receptor (LDLR).3 In some genome-wide associ-
ation studies (GWASs), low-risk variants for the hepatic 
cholesterol secretion (ABCG8 19H and ABCB4) have 
been associated with gallstone disease. It has been esti-
mated that the mutations in the hepatic cholesterol 
transporter ABCG8 confer the largest share of the 
genetic risk of developing gallstones.1 A meta-analysis 
of GWASs of individuals of European ancestry identi-
fied genetic risk variants for gallstone disease in ABCG8, 
TM4SF4, SULT2A1 and CYP7A1 genes.11
In view of the known inaccuracies in reporting family 
histories in case–control studies and the limited size of 
the published studies, we considered it timely to revisit 
familial risks of gallstone disease using the national 
cohort of Swedish families whose gallstones were medi-
cally diagnosed.12–15 In addition to the estimation of 
familial risks between genetically related relatives, we 
wanted to assess disease sharing between spouses in 
order to reconsider the contribution of the shared envi-
ronment in adulthood. The study covered 15.8 million 
individuals and 660 732 patients with gallstones.
PatIents and methods
Family relationships were obtained from the Multi-
generation Register, which contains family data 
on the Swedish population and spans more than a 
century. ‘The offspring generation’ was born after 
1931 and ‘the parental generation’ was born any 
time earlier. By the year 2015, the offspring genera-
tion had reached the age of 83 years; siblings can be 
defined only in the offspring generation. The offspring 
generation comprised 8.9 million index individuals 
in total. Patients with gallstones were identified using 
the nationwide Swedish Hospital Discharge Register 
(1964–2015) and the Outpatient Register (2001–2015). 
The first gallstone diagnosis in either register was 
considered and a patient was only entered once. Infor-
mation from the registers was linked at the individual 
level via the national 10-digit civic registration number, 
which is issued to all permanent residents in Sweden 
on birth or immigration to the country. In the linked 
dataset, civic registration numbers were replaced with 
serial numbers to ensure anonymity. Revisions 7 (1964–
1986), 9 (1987–1996) and 10 (1997–) of the Interna-
tional Classification of Diseases were used to identify 
gallstone diagnostic codes.
Standardised incidence ratios (SIRs) were calculated 
as the ratio of observed to expected number of cases. 
The expected numbers were calculated for all indi-
viduals without a history of gallstones (essentially the 
whole Swedish population), and the rates were stan-
dardised by 5-year-age, gender, period (5-year-group), 
socioeconomic status and residential area. The 95% CI 
of the SIR was calculated assuming a Poisson distribu-
tion. SIRs were calculated for offspring depending on 
the affected probands: parent, siblings or parents and 
siblings.
In order to assess possible roles of environmental risk 
factors for familial clustering of gallstones, we deter-
mined SIRs for gallstones in wives when husbands were 
diagnosed with gallstones and similarly for husbands 
when wives were diagnosed with gallstones. The period 
at risk for spouses was defined to start at the birth year 
of their first common child or at the first year that they 
were registered as living at the same address, whichever 
came first. The follow-up was terminated at gallstone 
diagnosis, death or when spouses no longer lived at the 
same address.16
The study was approved by the Regional Ethical Review 
Board of Lund University (no. 2012/795).
results
Patient numbers and mean diagnostic ages for gall-
stone disease are shown in table 1. The total popula-
tion included 15.8 million individuals with men slightly 
outnumbering women. Patients with gallstone disease 
amounted to 660 732. Women (436 257, 66.0%) signifi-
cantly outnumbered men (224  475). Mean and median 
diagnostic ages (ie, first hospital contact) were 55.7 and 
57 years, respectively. The overall incidence was 131 per 
100 000 person-years.
Familial risks are shown in table 2 in age groups of 
the offspring generation 0  to  83  year  old  for whom 
familial risks were calculated. The overall familial risks 
were almost identical for men (SIR 1.79) and women 
(SIR 1.75), giving an overall SIR of 1.76. However, 
Table 1 Population and number of cases of gallstone 
disease in Sweden, 1964–2015
Men Women All
Total population 8 025 741 7 790 505 15 816 246
Diagnosis of gallstone disease
  n 224 475 436 257 660 732
  Mean age at 
diagnosis 60.0±16.6 53.5±18.8 55.7±18.3
  Median age at 
diagnosis 61 54 57
  Incidence rate per 
100 000 person-
years* 87.8 176.2 131.1
*Age adjusted for European standardised population.
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female SIRs were higher than male SIRs until age 19, 
but at higher age there was a male excess. The maximal 
SIR was 2.68 for men and 3.01 for women; this was 
reached at age 10 to 19 years, after which age the SIR 
uniformly decreased to age 60+ years. The total number 
of familial gallstone disease patients was 111 273 in the 
offspring generation. The total number of patients 
with gallstone in the offspring generation numbered 
308 949, thus familial cases accounted for 36.0% of all 
patients with gallstone disease.
Age-specific incidence for all gallstone disease, with 
and without family history, is shown in figure 1. On top, 
female familial and non-familial incidence increased 
steeply up to ages 30 to 34, and after 34 years less 
steeply to age 75+ years. In bottom, male familial and 
non-familial incidence showed a continuous increase 
reaching the female rates at age 75+ years. At the repro-
ductive age, from 20 to 34 years, female familial and 
non-familial rates exceeded the male rates up to 5-fold.
Table 3 shows familial risks for gallstone disease 
by different probands. The SIRs were highest (2.58 
for men and women combined) when both a parent 
and a sibling were diagnosed with gallstone disease, 
compared with 1.62 when only a parent or 1.75 when 
only a sibling was diagnosed. The SIR was 2.44 when 
both parents were affected. Risks for sons were 1.71 
when fathers were affected compared with daughters’ 
SIR of 1.62 when mothers were affected. The difference 
was not large, but because of large case numbers, it was 
significant (ie, 95% CIs did not overlap). Table 3 also 
shows spousal risks, 1.18 for husbands of affected wives 
and also 1.18 for wives of affected husbands.
In table 4, we show familial risk for gallstone disease 
by the number of affected siblings. For both sexes 
combined, the SIR was 1.55 when one sibling was 
affected, and it increased to 10.16 for persons with two 
affected siblings. SIRs remained at that level if up to 
four or more siblings were affected. However, consid-
ering persons diagnosed before age 30 years, there was 
a continuous increase in risk in these four proband 
categories, 2.06, 11.77, 14.18 and 17.02, respectively. 
Male risks were uniformly higher than female risks, 
and the difference between SIRs increased by the 
number of affected siblings and was always highest in 
the early onset group, for example, 39.80 in men diag-
nosed before age 30 and who had four or more affected 
siblings compared with 15.06 in women in this cate-
gory. Data on siblings are shown figure 2, together with 
parental and spousal SIRs from table 3.
dIscussIon
The present study used nationwide hospital records on 
660 732 inpatients and outpatients who were medically 
diagnosed with gallstone disease. The national cohort 
design is, in principle, unbiased and the results consti-
tute by far the largest family study on gallstone disease 
yet published. The main novel finding was the complex 
population architecture of familial gallstone disease, 
with strong dependence of the risk on the age of onset 
and the number of affected family members, signalling 
genetic effects. Also, some unexpected results were 
found for the gender. Spousal correlation associated 
with gallstone disease, which signals environmental 
contributions, was modest. However, it was higher than 
reported in the literature but perhaps not unexpected 
because of the number of known environmental risk 
factors.10 The limitations of the study were unavail-
ability of primary care data, which may include persons 
with transient abdominal pain.
Familial cases, that is, persons in the offspring gener-
ation with a parent or a sibling with gallstone disease, 
accounted for 36.0% of all patients. The overall inci-
dence of gallstone disease (131 per 100 000 person-
years) was doubled in women compared with men. The 
largest difference between female and male incidence 
rates was noted at reproductive ages. Relatively few inci-
dence data are available from other countries. In the 
UK, age-standardised hospital admission rates for gall-
stone disease increased from 68.7 to 104.9 per 100 000 
population between 1989/1990 and 1999/2000; female 
rates were more than doubled compared with men.17 
Table 2 Familial SIR of gallstone disease by age groups
Men Women All
Age at diagnosis (years) O SIR 95% CI O SIR 95% CI O SIR 95% CI
0–9 46 1.59 1.16 to 2.12 55 2.22 1.67 to 2.90 101 1.88 1.53 to 2.28
10–19 444 2.68 2.44 to 2.95 2341 3.01 2.89 to 3.13 2785 2.95 2.84 to 3.06
20–29 2667 2.48 2.38 to 2.57 15 808 2.20 2.17 to 2.23 18 475 2.24 2.20 to 2.27
30–39 6293 2.11 2.06 to 2.16 19 471 1.84 1.82 to 1.87 25 764 1.90 1.88 to 1.92
40–49 8488 1.90 1.86 to 1.94 15 915 1.65 1.62 to 1.67 24 403 1.73 1.71 to 1.75
50–59 7763 1.67 1.64 to 1.71 13 474 1.55 1.52 to 1.58 21 237 1.59 1.57 to 1.61
60+ 7950 1.46 1.43 to 1.49 10 558 1.40 1.38 to 1.43 18 508 1.43 1.41 to 1.45
All 33 651 1.79 1.77 to 1.81 77 622 1.75 1.73 to 1.76 1 11 273 1.76 1.75 to 1.77
O, observed number of cases; SIR, standardised incidence ratio.
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The increasing trend appears to continue in developed 
countries.1 18 19 In Taiwan, hospitalisation rates were 
about 60 per 100 000 for both men and women around 
the year 2000.20 It is noteworthy if the female excess 
in gallstone disease is a feature of western populations.
The total number of familial gallstone disease 
patients was 111 273 in the offspring generation 0 to 
83  years old. Of these, 50.9% had a parental family 
history (SIR 1.62), 35.1% had a sibling family history 
(SIR 1.75) and 14.0% had a parental+sibling family 
history (SIR 2.58). Among a total of 54 626 affected 
siblings, 84.4% were sibling pairs (SIR 1.55). However, 
the remaining 15.6% of the affected siblings consti-
tuted the high-risk group with an SIR >10; these 8527 
persons accounted for 7.7% of all affected offspring. 
In this high-risk group, those diagnosed before the age 
of 30 years were at the highest risk, particularly if they 
were men. It is noteworthy that despite the doubled 
incidence in women, the overall familial risks were 
only marginally higher in men, but in the highest risk 
groups, they were much higher. Thus, the citation 
from the Introduction ‘female relatives of young gall-
stone patients should be routinely screened for gall-
stones’ should be modified from focusing on gender 
Figure 1 Incidence of gallstone disease in women (top) and men (bottom) per 100 000 person-years. Note that the difference 
between the curves is an estimate of crude incidence rates.
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to a defined family history.7 The high-risk group consti-
tutes families with at least two affected siblings.
In conclusion, the present results provide qualified 
evidence for the familial risk in gallstone disease, which 
covered 36.0% of all patients with gallstone disease in 
our study. The patterns of familial clustering suggest 
that the large majority of the population, with one 
affected family member, are at a 1.6-fold to 1.7-fold risk 
of being hospitalised for gallstone disease. A smaller 
group, which has both parents or a parent and a sibling 
diagnosed with gallstone disease, run a higher risk of 
about 2.5. The high-risk population constitutes those 
with at least two siblings, some 7.7% of all familial gall-
stone disease patients, and their risk is over 10-fold the 
background rate. One can assume that the majority of 
the familial risk is contributed by gene–environment 
interactions at a polygenic background of common 
low-risk variants while the high-risk population carries 
gene variants with high to moderate penetrance.1 3 11 
It would be useful that clinical guidelines for gallstone 
disease would also consider prevention and counselling 
about avoidance of risk factors with a focus on patients 
and healthy individuals from high-risk families.21 The 
present results about familial risk should reassure 
Table 3 Familial SIR of gallstone disease
Men Women All
Probands O SIR 95% CI O SIR 95% CI O SIR 95% CI
Parent 21 345 1.65 1.63 to 1.68 50 910 1.63 1.62 to 1.64 72 255 1.64 1.62 to 1.65
Both parents 1682 2.63 2.50 to 2.76 3710 2.37 2.29 to 2.44 5392 2.44 2.38 to 2.51
Father 8688 1.71 1.68 to 1.75 18 991 1.55 1.53 to 1.57 27 679 1.60 1.58 to 1.62
Mother 14 341 1.57 1.55 to 1.60 35 629 1.62 1.60 to 1.64 49 970 1.61 1.59 to 1.62
Sibling 17 182 1.82 1.79 to 1.85 37 448 1.76 1.75 to 1.78 54 630 1.78 1.77 to 1.80
Both parent and 
sibling 4876 2.69 2.62 to 2.77 10 734 2.53 2.49 to 2.58 15 610 2.58 2.54 to 2.62
Only parent 16 469 1.64 1.61 to 1.66 40 174 1.62 1.60 to 1.63 56 643 1.62 1.61 to 1.64
Only sibling 12 306 1.78 1.75 to 1.81 26 712 1.74 1.72 to 1.76 39 018 1.75 1.73 to 1.77
Spouses 20 704 1.18 1.17 to 1.20 20 704 1.18 1.17 to 1.20 41 408 1.18 1.17 to 1.19
 O, observed number of cases; SIR, standardised incidence ratio.
Table 4 SIR of gallstone disease among siblings
Men Women All
Siblings O SIR 95% CI O SIR 95% CI O SIR 95% CI
One sibling 14 416 1.56 1.54 to 1.59 31 683 1.54 1.52 to 1.56 46 099 1.55 1.53 to 1.56
  <30 1043 2.17 2.04 to 2.31 6558 2.04 1.99 to 2.09 7601 2.06 2.01 to 2.10
  40–49 5955 1.75 1.70 to 1.79 13 996 1.56 1.53 to 1.58 19 951 1.61 1.59 to 1.63
  50+ 7418 1.39 1.36 to 1.42 11 129 1.32 1.30 to 1.35 18 547 1.35 1.33 to 1.37
Two siblings 2233 12.76 12.23 to 13.30 4651 9.25 8.99 to 9.52 6884 10.16 9.92 to 10.40
  <30 155 20.39 17.31 to 23.87 1018 11.06 10.39 to 11.76 1173 11.77 11.11 to 12.47
  40–49 909 13.70 12.83 to 14.62 1977 8.65 8.27 to 9.04 2886 9.79 9.43 to 10.15
  50+ 1169 11.56 10.91 to 12.25 1656 9.10 8.67 to 9.55 2825 9.98 9.62 to 10.36
Three siblings 415 11.84 10.72 to 13.03 898 9.58 8.96 to 10.22 1313 10.19 9.65 to 10.76
  <30 37 25.78 18.14 to 35.56 217 13.17 11.47 to 15.04 254 14.18 12.49 to 16.03
  40–49 158 12.31 10.46 to 14.39 375 8.66 7.81 to 9.59 533 9.50 8.71 to 10.34
  50+ 220 10.58 9.23 to 12.08 306 9.00 8.02 to 10.06 526 9.60 8.79 to 10.45
Four or more 
siblings 115 14.78 12.20 to 17.74 215 9.46 8.24 to 10.81 330 10.81 9.68 to 12.05
  <30 15 39.80 22.21 to 65.80 66 15.06 11.65 to 19.17 81 17.02 13.52 to 21.16
  40–49 49 16.56 12.25 to 21.91 80 7.85 6.23 to 9.78 129 9.81 8.19 to 11.66
  50+ 51 11.47 8.54 to 15.09 69 8.45 6.57 to 10.70 120 9.52 7.89 to 11.38
O, observed number of cases; SIR, standardised incidence ratio.
by copyright.
 on 20 F










astroenterol: first published as 10.1136/bm






6 Hemminki K, et al. BMJ Open Gastro 2017;4:e000188. doi:10.1136/bmjgast-2017-000188
Open Access 
about the importance of taking a detailed family history 
in the clinical setting and of targeting counselling 
accordingly.
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